BetterLife Pharma, Inc. is an emerging biotechnology company, which focuses on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. The firm owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development. The company was founded on June 10, 2002 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BetterLife Pharma Inc market cap is $86M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. BetterLife Pharma Inc 52 week high is $0.3311 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BetterLife Pharma Inc 52 week low is $0.0276 as of November 22, 2026.
BetterLife Pharma Inc stock price today is $0.1392.
BetterLife Pharma Inc stock price yesterday was $0.1376.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. BetterLife Pharma Inc's P/E ratio is -8.81.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BetterLife Pharma Inc P/B ratio is -2.9525.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BetterLife Pharma Inc 50-day moving average is $0.1858.